Douglas Mental Health University Institute
Douglas Mental Health University Institute
Montreal, Quebec, Canada6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use | Chemically-Induced Disorders, Cognition Disorders, Cognitive Dysfunction, Memory Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, cannabis dependence, cognitive disorder, nervous system disorder, psychiatric disorder, schizophrenia, substance-related disorder | Recruiting | Not applicable | 2026-09-15 | NCT05445180 | |
| Brexpiprazole Treatment for Bipolar I Depression | Bipolar and Related Disorders, Depressive Disorder, Treatment-Resistant, bipolar disorder, depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 3 | 2026-08-27 | NCT04569448 | |
| ERG Components in Schizophrenia and Bipolar Disorder Type I | Schizophrenia Spectrum and Other Psychotic Disorders, bipolar I disorder, psychiatric disorder, schizophrenia | Active, not recruiting | Not stated | 2025-08-22 | NCT03788811 | |
| Magnetoencephalography in Psychosis Program | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, communication disorder, language disorder, nervous system disorder, psychiatric disorder, schizophrenia | Enrolling by invitation | Not stated | 2025-05-18 | NCT06978881 | |
| HYEEG Discourse in Psychosis: A Neurobehavioural Study | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Not stated | 2025-05-18 | NCT06978803 | |
| Cannabidiol for Bipolar Depression (CBD-BD) | Bipolar and Related Disorders, bipolar disorder, depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 3 | 2025-04-23 | NCT05867849 |